Breast cancer and the immune system
- PMID: 19134448
- PMCID: PMC2845458
Breast cancer and the immune system
Abstract
This article reviews the evidence that the functioning of both the innate and the adaptive immune system plays a role in preventing relapse in women with breast cancer. Lymphocytes, including T cells, T regulatory cells, and natural killer cells, and their cytokine release patterns are implicated in both primary prevention and recurrence of breast cancer. Cancer prognosis may be related to immune system functional status. The hypothesis that the immune system has a causal role in breast cancer etiology is supported by epidemiologic, preclinical, and clinical research. Empirical support for the concept that immune status and immunomodulatory therapy have important roles in comprehensive breast cancer treatment is provided.
Similar articles
-
Adaptive immunity programmes in breast cancer.Immunology. 2017 Jan;150(1):25-34. doi: 10.1111/imm.12664. Epub 2016 Sep 20. Immunology. 2017. PMID: 27564847 Free PMC article. Review.
-
Assessment of host immune response in breast cancer patients.Cancer Detect Prev. 1986;9(3-4):311-7. Cancer Detect Prev. 1986. PMID: 3488806
-
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.Breast Cancer Res. 2007;9(4):212. doi: 10.1186/bcr1746. Breast Cancer Res. 2007. PMID: 17705880 Free PMC article. Review.
-
[The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].Vopr Onkol. 1992;38(7):787-92. Vopr Onkol. 1992. PMID: 1300783 Russian.
-
[Tumor-induced immunosuppression in breast cancer patients].Eksp Onkol. 1990;12(5):53-6. Eksp Onkol. 1990. PMID: 2226260 Russian.
Cited by
-
Evolving concepts: how diet and the intestinal microbiome act as modulators of breast malignancy.ISRN Oncol. 2013 Sep 25;2013:693920. doi: 10.1155/2013/693920. ISRN Oncol. 2013. PMID: 24187630 Free PMC article. Review.
-
Integrative Oncology's 30-Year Anniversary: What Have We Achieved? A North American Naturopathic Oncology Perspective.Integr Cancer Ther. 2023 Jan-Dec;22:15347354231178911. doi: 10.1177/15347354231178911. Integr Cancer Ther. 2023. PMID: 37294048 Free PMC article. Review.
-
Investigation of the immunological effects of escitalopram oxalate in the breast cancer co-culture model.Asian Biomed (Res Rev News). 2024 Jun 28;18(3):133-145. doi: 10.2478/abm-2024-0019. eCollection 2024 Jun. Asian Biomed (Res Rev News). 2024. PMID: 39175950 Free PMC article.
-
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.J Transl Med. 2015 Jun 4;13:180. doi: 10.1186/s12967-015-0535-8. J Transl Med. 2015. PMID: 26040463 Free PMC article.
-
Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study.PLoS One. 2024 Mar 1;19(3):e0289519. doi: 10.1371/journal.pone.0289519. eCollection 2024. PLoS One. 2024. PMID: 38427628 Free PMC article.
References
-
- Melief CJ, Kast WM. Lessons from T cell responses to virus induced tumours for cancer eradication in general. Cancer Surv. 1992;13:81–99. - PubMed
-
- Cunningham-Rundles S, Filippa DA, Braun DW, Jr, et al. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J Natl Cancer Inst. 1981;67:585–590. - PubMed
-
- Levy S, Herberman R, Lippman M, d’Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 1987;5:348–353. - PubMed
-
- Strayer DR, Carter WA, Mayberry SD, et al. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer Res. 1984;44:370–374. - PubMed
-
- Schantz SP, Peters LJ. Patterns of recurrence from head and neck cancer. An immunologic perspective. Am J Clin Oncol. 1987;10:469–474. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical